VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
FENC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
FENCFennec Pharmaceuticals Inc.
$10.08$350M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFENCQuarterly Balance Sheet

Fennec Pharmaceuticals Inc. (FENC) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Fennec Pharmaceuticals Inc. (FENC) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

FENC Balance Sheet

Quarterly statement

FENC Balance Sheet

Fennec Pharmaceuticals Inc. (FENC) balance sheet — 26-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets72.5M66.88M67.04M46.06M40.79M42.98M44.12M57.97M62.17M68.17M26.86M18.95M19.33M21.66M26.73M30.15M15.55M19.13M22.39M25.98M
Cash & Short-Term Investments41.25M40.18M36.79M21.95M18.7M22.68M26.63M40.32M43.05M51.18M13.27M12.4M14.96M18.39M23.77M29.75M14.91M18.26M21.1M24.34M
Cash Only41.25M40.18M36.79M21.95M18.7M22.68M26.63M40.32M43.05M51.18M13.27M12.4M14.96M18.39M23.77M29.75M14.91M18.26M21.1M24.34M
Short-Term Investments00000000000000000000
Accounts Receivable23.27M18.76M23.22M19.34M17.5M15.45M12.88M12.91M12.31M10.27M8.81M4.53M2.44M1.68M1.54M00000
Days Sales Outstanding106.99125.05142.12136155.33145.69149.71166.35141.5134.2263.0349.2156.4986.6292.6-----
Inventory2.37M1.86M1.56M2.48M2.2M1.4M1.06M1.13M2.14M2.06M2.16M1.75M1.44M918K576K00000
Days Inventory Outstanding266.94270.08105.4326.04169.63297.27150.24110.81314.91349.11262.64443.88724.62707.68616.19-----
Other Current Assets1.98M2.62M1.73M898K965K1M466K546K283K161K44K20K32K32K63K123K149K154K253K412K
Total Non-Current Assets3.25M4.94M3.51M3.2M4.08M3.43M822K956K989K1.02M6K82K106K159K211K264K14K21K27K35K
Property, Plant & Equipment0000000000028.86K00000000
Fixed Asset Turnover-----------225.74x--------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments04.25M003.32M000000000000000
Other Non-Current Assets3.25M691K3.51M3.2M760.63K3.43M822K956K989K1.02M6K53.14K106K159K211K264K14K21K27K35K
Total Assets75.75M71.82M70.55M49.26M44.88M46.4M44.95M58.92M63.16M69.19M26.86M19.03M19.44M21.82M26.94M30.42M15.57M19.15M22.41M26.01M
Asset Turnover0.24x0.21x0.23x0.26x0.21x0.19x0.15x0.11x0.11x0.53x0.42x0.34x0.16x0.07x0.05x-----
Asset Growth %68.81%54.78%56.97%-16.39%-28.95%-32.94%67.31%209.65%224.95%217.09%-0.28%-37.44%24.85%13.95%20.19%16.93%-44.63%-31.18%-28.66%-23.65%
Total Current Liabilities12.39M9.59M10.52M9.81M8.41M8.37M6.92M7.43M7.75M9.84M7.55M3.91M3.78M4.02M4.61M2.93M3.04M2.14M1.65M2.01M
Accounts Payable5.52M6.28M4.63M5.87M5.94M5.28M3.24M3.87M4.45M5.2M3.78M2.94M3M2.95M2.39M2.53M1.74M1.22M777K1.15M
Days Payables Outstanding744.47861.79273.84822.91527.981.03K488.74281.83722.24743.06451.2826.331.83K2.53K2.63K-----
Short-Term Debt00000000000000001M500K00
Deferred Revenue (Current)3.18M248K248K248K248K000000000000000
Other Current Liabilities00000248K248K248K252K252K000-1000000
Current Ratio5.85x6.98x6.37x4.69x4.85x5.13x6.38x7.80x8.02x6.93x3.56x4.84x5.12x5.39x5.80x10.30x5.12x8.96x13.54x12.90x
Quick Ratio5.66x6.78x6.23x4.44x4.59x4.97x6.22x7.64x7.75x6.72x3.27x4.39x4.74x5.16x5.67x10.30x5.12x8.96x13.54x12.90x
Cash Conversion Cycle-370.54-466.66-26.32-360.87-203.03-585.05-188.79-4.67-265.82-359.72-125.54-333.24-1.05K-1.73K-1.92K-----
Total Non-Current Liabilities20.92M24.56M24.56M43.94M43.92M43.91M43.9M56.66M56.77M56.34M30.93M25.65M25.39M25.14M24.9M24.69M3.99M4.49M4.99M4.99M
Long-Term Debt00019.38M19.36M19.35M19.34M32.1M31.77M31.35M30.93M25.64M25.39M25.14M24.9M24.69M3.99M4.49M4.99M4.99M
Capital Lease Obligations00000000002K7K00000000
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities0000024.56M24.56M24.56M24.99M24.99M0001000000
Total Liabilities33.31M34.15M35.08M53.75M52.34M52.28M50.82M64.09M64.52M66.18M38.49M29.56M29.16M29.16M29.51M27.61M7.03M6.63M6.64M7M
Total Debt00019.38M19.36M19.35M19.34M32.1M31.79M31.37M30.95M25.67M25.39M25.14M24.9M24.69M4.99M4.99M4.99M4.99M
Net Debt-41.25M-40.18M-36.79M-2.57M659K-3.32M-7.29M-8.22M-11.27M-19.82M17.68M13.27M10.43M6.75M1.13M-5.06M-9.93M-13.27M-16.11M-19.35M
Debt / Equity---------10.41x-----8.81x0.58x0.40x0.32x0.26x
Debt / EBITDA---------2.17x----------
Net Debt / EBITDA-23.40x---------1.37x----------
Interest Coverage579.00x29.71x-14.20x-0.09x-4.15x-0.95x-0.68x-4.60x-4.23x13.41x-1.93x-1.18x-5.08x-6.58x-7.50x-66.97x-88.74x-62.72x--75.61x
Total Equity42.44M37.67M35.47M-4.49M-7.46M-5.88M-5.87M-5.17M-1.36M3.01M-11.62M-10.53M-9.73M-7.34M-2.57M2.8M8.54M12.52M15.77M19.01M
Equity Growth %668.7%740.73%704.09%13.13%-449.96%-295.09%49.48%50.9%86.05%141.07%-352.39%-475.84%-213.89%-158.6%-116.29%-85.26%-61.67%-49.77%-45.74%-39.03%
Book Value per Share1.171.061.14-0.16-0.27-0.21-0.21-0.19-0.050.10-0.43-0.40-0.37-0.28-0.100.110.330.480.610.73
Total Shareholders' Equity42.44M37.67M35.47M-4.49M-7.46M-5.88M-5.87M-5.17M-1.36M3.01M-11.62M-10.53M-9.73M-7.34M-2.57M2.8M8.54M12.52M15.77M19.01M
Common Stock193.19M191.23M189.91M147.65M146.16M145.98M145.61M145.44M145.28M144.93M144.31M143.56M143.34M142.8M142.59M141.31M140.92M140.83M140.8M140.78M
Retained Earnings-227.25M-229.22M-229.42M-224.64M-224M-220.85M-219.68M-217.7M-211.96M-206.41M-219.25M-216.56M-214.7M-209.25M-203.2M-196.34M-188.25M-183.18M-179.49M-175.06M
Treasury Stock00000000000000000000
Accumulated OCI1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M1.24M
Minority Interest00000000000000000000